
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Israel's fractured opposition hands Netanyahu a full term - 2
It's been 20 years since MTV's golden couple split. These producers saw it all unravel. - 3
Australia Cracks Down on Gambling Ads as Prediction Markets Like Polymarket Remain Blocked - 4
Why most Jewish Israelis back the death penalty for terrorists - 5
How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
'All's Fair,' Ryan Murphy's new show starring Kim Kardashian, hit with scathing reviews: 'A girlboss fever dream'
Reactions as Artemis II astronauts lift off on historic lunar mission
Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
UK, Canada, Germany, others condemn Israel's West Bank settlement plan
The Force of Positive Reasoning: Day to day Attestations
Public Parks in the USA
Relish the World: Notable Caf\u00e9s You Really want to Attempt
How does spider venom damage human cells? Researchers uncover the killer mechanism of recluse spider toxin











